Preferred Label : Human Milk Oligosaccharides-based Formulation PBCLN-010;
NCIt definition : An orally bioavailable formulation containing human milk oligosaccharides (HMOs),
with potential microbiome-enhancing, protective and immunomodulating activities. Upon
oral administration, HMO-based formulation PBCLN-010 provides HMOs to the unhealthy,
altered gut microbiome and enables the growth of diverse beneficial bacteria in the
gut. This improves the immune system, suppresses inflammation, and enhances intestinal
barrier function. This may lower the risk of GI antibiotic-resistant bacterial infections,
bacteremia and graft-versus-host disease (GvHD) in patients undergoing solid organ
and allogeneic stem cell transplantation.;
Molecule name : PBCLN 010; PBCLN-010;
NCI Metathesaurus CUI : CL1921182;
Origin ID : C202211;
UMLS CUI : C5907947;
Semantic type(s)
- concept_is_in_subset
